Paradigm Spine said today it won coverage for its Coflex interlaminar stabilization device intended to treat lumbar spinal stenosis from AmeriHealth Caritas.
The Coflex interlaminar stabilization system is the New York-based company’s flagship device, and is designed for posterior lumbar preservation in patients with moderate to severe spinal stenosis.
With the coverage, an additional 5.3 million individuals will be able to receive treatments with the Coflex device, the company said.
“With this continued payor coverage momentum, we look forward to further expanding access to our Coflex solution, which is backed by more than 90 peer-reviewed published articles, including landmark long-term follow-up clinical studies, and spine medical society guidelines,” chair & CEO Marc Viscogliosi said in a press release.
Earlier this month, RTI Surgical (NSDQ:RTIX) agreed to put $300 million on the table for Paradigm Spine and its Coflex lumbar stenosis device.
